Phosphoproteomic analysis identifies insulin enhancement of discoidin domain receptor 2 phosphorylation

Cell Adhesion and Migration

Volumn 7, Issue 2, 2013, Pages 161-164

  Iwai, Leo K ^a   Chang, Francis ^a   Huang, Paul H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Discoidin domain receptor 2; Insulin; Mass spectrometry; Proteomics; Signal transduction

Indexed keywords

COLLAGEN TYPE 1; DISCOIDIN DOMAIN RECEPTOR 2; INSULIN; INSULIN RECEPTOR; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84878788785     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.22572     Document Type: Article

References (24)

1. Vogel WF, Abdulhussein R, Ford CE. Sensing extracellular matrix: an update on discoidin domain receptor function. Cell Signal 2006; 18:1108-16; PMID:16626936; http://dx.doi.org/10.1016/j.cell-sig.2006.02.012
2. Leitinger B, Kwan AP. The discoidin domain receptor DDR2 is a receptor for type X collagen. Matrix Biol 2006; 25:355-64; PMID:16806867; http://dx.doi.org/10.1016/j.matbio.2006.05.006
3. Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R. Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev 2012; 31:295-321; PMID:22366781; http://dx.doi.org/10.1007/s10555-012-9346- z
4. Olaso E, Ikeda K, Eng FJ, Xu L, Wang LH, Lin HC, et al. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest 2001; 108:1369-78; PMID:11696582.
5. Xu L, Peng H, Wu D, Hu K, Goldring MB, Olsen BR, et al. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J Biol Chem 2005; 280:548-55; PMID:15509586.
6. Blissett AR, Garbellini D, Calomeni EP, Mihai C, Elton TS, Agarwal G. Regulation of collagen fibrillogenesis by cell-surface expression of kinase dead DDR2. J Mol Biol 2009; 385:902-11; PMID:18996394; http://dx.doi.org/10.1016/j. jmb.2008.10.060
7. Mihai C, Iscru DF, Druhan LJ, Elton TS, Agarwal G. Discoidin domain receptor 2 inhibits fibrillogenesis of collagen type 1. J Mol Biol 2006; 361:864-76; PMID:16884738; http://dx.doi.org/10.1016/j.jmb.2006.06.067
8. Xu AM, Huang PH. Receptor tyrosine kinase coactivation networks in cancer. Cancer Res 2010; 70:3857-60; PMID:20406984; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-0163
9. Tian T, Olson S, Whitacre JM, Harding A. The origins of cancer robustness and evolvability. Integr Biol (Camb) 2011; 3:17-30; PMID:20944865; http://dx.doi.org/10.1039/c0ib00046a
10. Borisov N, Aksamitiene E, Kiyatkin A, Legewie S, Berkhout J, Maiwald T, et al. Systems-level interactions between insulin-EGF networks amplify mitogenic signaling. Mol Syst Biol 2009; 5:256; PMID:19357636; http://dx.doi.org/10.1038/ msb.2009.19
11. Vogel W, Brakebusch C, Fässler R, Alves F, Ruggiero F, Pawson T. Discoidin domain receptor 1 is activated independently of beta(1) integrin. J Biol Chem 2000; 275:5779-84; PMID:10681566; http://dx.doi.org/10.1074/jbc.275.8. 5779
12. Beitner-Johnson D, LeRoith D. Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk. J Biol Chem 1995; 270:5187-90; PMID:7534289; http://dx.doi.org/10.1074/jbc.270.10.5187
13. Schmelzle K, Kane S, Gridley S, Lienhard GE, White FM. Temporal dynamics of tyrosine phosphorylation in insulin signaling. Diabetes 2006; 55:2171-9; PMID:16873679; http://dx.doi.org/10.2337/db06-0148
14. Krüger M, Kratchmarova I, Blagoev B, Tseng YH, Kahn CR, Mann M. Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc Natl Acad Sci U S A 2008; 105:2451-6; PMID:18268350; http://dx.doi.org/10. 1073/pnas.0711713105
15. Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1997; 1:13-23; PMID:9659899; http://dx.doi.org/10.1016/S1097-2765(00)80003-9
16. Yang K, Kim JH, Kim HJ, Park IS, Kim IY, Yang BS. Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation. J Biol Chem 2005; 280:39058-66; PMID:16186108; http://dx.doi.org/10.1074/jbc.M506921200
17. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG Jr., Glasheen E, et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995; 377:173-7; PMID:7675087; http://dx.doi.org/10.1038/377173a0
18. Labrador JP, Azcoitia V, Tuckermann J, Lin C, Olaso E, Mañes S, et al. The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep 2001; 2:446-52; PMID:11375938.
19. Lin KL, Chou CH, Hsieh SC, Hwa SY, Lee MT, Wang FF. Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation. J Bone Miner Res 2010; 25:2489-503; PMID:20564243; http://dx.doi.org/10.1002/jbmr.159
20. Yang J, Zhang X, Wang W, Liu J. Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells. Cell Biochem Funct 2010; 28:334-41; PMID:20517899; http://dx.doi.org/10.1002/cbf.1668
21. Kato K, Yazawa T, Taki K, Mori K, Wang S, Nishioka T, et al. The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration. Mol Biol Cell 2012; 23:2593-604; PMID:22593208; http://dx.doi.org/ 10.1091/mbc.E11-11-0958
22. Prasad N, Topping RS, Decker SJ. SH2-containing inositol 5′-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol Cell Biol 2001; 21:1416-28; PMID:11158326; http://dx.doi.org/10.1128/MCB.21.4.1416-1428.2001
23. Lemeer S, Bluwstein A, Wu Z, Leberfinger J, Müller K, Kramer K, et al. Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1. J Proteomics 2012; 75:3465-77; PMID:22057045; http://dx.doi.org/10. 1016/j.jprot.2011.10.007
24. Kelber JA, Klemke RL. PEAK1, a novel kinase target in the fight against cancer. Oncotarget 2010; 1:219-23; PMID:21301050.